Gov. Christie’s Opioid Commission and the Nation’s Biggest Nightmare – J. David Haddox, MD, DDS

CaptureHow many lives could have been saved?

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH)  This should scare anyone involved in the prescription opioid/heroin epidemic. J. David Haddox, MD, DDS is the “gate keeper” at Purdue Pharma and successfully downplayed the dangers of OxyContin in the late 1990’s. Haddox “coined” a word “pseudo-addiction” without scientific data.  The definition of Haddox’s word “pseudo-addiction” is A drug-seeking behavior that simulates true addiction, which occurs in patients with pain who are receiving inadequate pain medication. So Haddox’s message to the medical profession was “more” is appropriate when treating patients with dangerous narcotics — and the medical profession bought it. In the meantime, Haddox’s employer, Purdue Pharma made billions of dollars in the sale of their drug OxyContin — as lives were ended.

Peoples Live Stage

Global News Centre

Submitted: Direct Exchange By Affiliation

Our goal is to give aspiring new talent an opportunity to be introduced to the general public for their enjoyment and recognition.

ATRAYO: SOUL OF KHALID

a

Global News Centre

Submitted: Direct Exchange By Affiliation  

Caught you US Senator Orrin Hatch! Release the Opioid Report Now !

Orrin Hatch

Senator (R-UT) Orrin Hatch

 

Mr. Hatch — it’s called obstruction of justice and I will continue reporting on you until the US Senate Finance Committee investigation on prescription opioids is made public.

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH) In the 15 years I have been reporting on the prescription opioid epidemic, it has in some ways been frustrating to be a forerunner in exposing the criminal activity of pharma, the FDA, politicians, physicians, pain foundations and organizations profiting from the surging death and addiction rates — while US Senator Orrin Hatch is allowed to obstruct justice.

Why Tom Marino won’t be confirmed as Drug Czar by the U.S. Senate

Tom Marino

Tom Marino

Marino’s support of Trump in 2016 presidential election may have played into his appointment by the President as Drug Czar

Marianne Skolek-Perez Global News Centre

(MYRTLE BEACH) President Trump announced that he was nominating Rep. Tom Marino (R) of Pennsylvania to head the Office of National Drug Control Policy for the second time. Marino had cited personal reasons for turning down the prestigious position several months ago. His personal reasons “resolved” themselves and Marino was appointed for a second time by Trump. That appointment is now in the U.S. Senate for confirmation.

Web Design BangladeshBangladesh Online Market